Acuta Capital Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $7.32M | Buy |
|
|||||
|
2022
Q2 | $6.34M | Buy |
|
|||||
|
2022
Q1 | $4.32M | Buy |
|
|||||
|
2021
Q4 | $2.93M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.54M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.32M | Sell |
|
|||||
|
2019
Q2 | $6.44M | Buy |
|
|||||
|
2019
Q1 | $3M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $3.07M | Sell |
|
|||||
|
2017
Q4 | $2.83M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $826K | Hold |
|
|||||
|
2016
Q2 | $683K | Buy |
|
|||||
|
2016
Q1 | $2.21M | Buy |
|
|||||
|
2015
Q4 | $2.79M | Buy |
|